ASX Health Stocks: Althea’s cannabis oil approved for reimbursement in Ireland, Imugene begins Phase 1 trial
Cannabis stock Althea’s THC20:CBD1 cannabis oil (50 ml) is now approved for reimbursement in Ireland. Imugene doses first patient in Phase 1.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
